Peer Review reports
From: MYCN protein stability is a better prognostic indicator in neuroblastoma
Original Submission | ||
---|---|---|
9 Jan 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
13 Feb 2022 | Reviewed | Reviewer Report |
6 Mar 2022 | Reviewed | Reviewer Report |
24 Mar 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 3 | ||
24 Mar 2022 | Submitted | Manuscript version 3 |
28 Mar 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 4 | ||
28 Mar 2022 | Submitted | Manuscript version 4 |
7 Apr 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 5 | ||
7 Apr 2022 | Submitted | Manuscript version 5 |
9 Apr 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 6 | ||
9 Apr 2022 | Submitted | Manuscript version 6 |
12 Apr 2022 | Reviewed | Reviewer Report |
15 Apr 2022 | Reviewed | Reviewer Report |
15 May 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 7 | ||
15 May 2022 | Submitted | Manuscript version 7 |
23 May 2022 | Reviewed | Reviewer Report |
17 Jun 2022 | Author responded | Author comments - Yanxin Li |
Resubmission - Version 8 | ||
17 Jun 2022 | Submitted | Manuscript version 8 |
Publishing | ||
23 Jun 2022 | Editorially accepted | |
11 Jul 2022 | Article published | 10.1186/s12887-022-03449-1 |
You can find further information about peer review here.